Subramanian S, Phongbunchoo Y, Cauchy P, Ramamoorthy S
Methods Mol Biol. 2025; 2909:179-209.
PMID: 40029523
DOI: 10.1007/978-1-0716-4442-3_13.
Vllahu M, Savarese M, Cantiello I, Munno C, Sarcina R, Stellato P
Biomedicines. 2025; 13(2).
PMID: 40002837
PMC: 11852417.
DOI: 10.3390/biomedicines13020424.
Fedl A, Tagoh H, Gruenbacher S, Sun Q, Schenk R, Froussios K
Nat Immunol. 2024; 25(9):1663-1677.
PMID: 39179932
DOI: 10.1038/s41590-024-01933-7.
Ramani M, Singh R, Shrivastva S, Ribeyron L, Gupta S, Roy A
J Biol Chem. 2024; 300(8):107578.
PMID: 39029626
PMC: 11367411.
DOI: 10.1016/j.jbc.2024.107578.
Kastner P, Chan S
Adv Exp Med Biol. 2024; 1459:33-52.
PMID: 39017838
DOI: 10.1007/978-3-031-62731-6_2.
Multifaceted roles of gene, perspectives from bench to bedside.
Feng L, Zhang H, Liu T
Front Oncol. 2024; 14:1383419.
PMID: 38978740
PMC: 11228169.
DOI: 10.3389/fonc.2024.1383419.
Loss of β2-integrin function results in metabolic reprogramming of dendritic cells, leading to increased dendritic cell functionality and anti-tumor responses.
Harjunpaa H, Somermaki R, Saldo Rubio G, Fusciello M, Feola S, Faisal I
Oncoimmunology. 2024; 13(1):2369373.
PMID: 38915784
PMC: 11195491.
DOI: 10.1080/2162402X.2024.2369373.
An integrated classification of tumor suppressor inactivation and oncogenic activation in Philadelphia chromosome-like acute lymphoblastic leukemia.
Huang Z, Zhang L, Gong X, Li J, Deng S, Cai Z
Hemasphere. 2024; 8(5):e82.
PMID: 38774654
PMC: 11106797.
DOI: 10.1002/hem3.82.
Emerging paradigms in cancer cell plasticity.
Huh H, Park H
BMB Rep. 2024; 57(6):273-280.
PMID: 38627950
PMC: 11214895.
A noncoding regulatory variant in IKZF1 increases acute lymphoblastic leukemia risk in Hispanic/Latino children.
de Smith A, Wahlster L, Jeon S, Kachuri L, Black S, Langie J
Cell Genom. 2024; 4(4):100526.
PMID: 38537633
PMC: 11019360.
DOI: 10.1016/j.xgen.2024.100526.
Alterations and Therapeutic Targeting in B-Cell Acute Lymphoblastic Leukemia.
Paolino J, Tsai H, Harris M, Pikman Y
Biomedicines. 2024; 12(1).
PMID: 38255194
PMC: 10813044.
DOI: 10.3390/biomedicines12010089.
Concepts in B cell acute lymphoblastic leukemia pathogenesis.
Garcia C, Miller-Awe M, Witkowski M
J Leukoc Biol. 2024; 116(1):18-32.
PMID: 38243586
PMC: 11869204.
DOI: 10.1093/jleuko/qiae015.
Lineage-specific 3D genome organization is assembled at multiple scales by IKAROS.
Hu Y, Figueroa D, Zhang Z, Veselits M, Bhattacharyya S, Kashiwagi M
Cell. 2023; 186(24):5269-5289.e22.
PMID: 37995656
PMC: 10895928.
DOI: 10.1016/j.cell.2023.10.023.
IKAROS: from chromatin organization to transcriptional elongation control.
Affar M, Bottardi S, Quansah N, Lemarie M, Ramon A, Affar E
Cell Death Differ. 2023; 32(1):37-55.
PMID: 37620540
PMC: 11742659.
DOI: 10.1038/s41418-023-01212-2.
Stromal-induced epithelial-mesenchymal transition induces targetable drug resistance in acute lymphoblastic leukemia.
Park C, Yoshihara H, Gao Q, Qu C, Iacobucci I, Ghate P
Cell Rep. 2023; 42(7):112804.
PMID: 37453060
PMC: 10529385.
DOI: 10.1016/j.celrep.2023.112804.
Integrins and the Metastasis-like Dissemination of Acute Lymphoblastic Leukemia to the Central Nervous System.
Modvig S, Jeyakumar J, Marquart H, Christensen C
Cancers (Basel). 2023; 15(9).
PMID: 37173970
PMC: 10177281.
DOI: 10.3390/cancers15092504.
IKAROS in Acute Leukemia: A Positive Influencer or a Mean Hater?.
Conserva M, Redavid I, Anelli L, Zagaria A, Tarantini F, Cumbo C
Int J Mol Sci. 2023; 24(4).
PMID: 36834692
PMC: 9961161.
DOI: 10.3390/ijms24043282.
A double-negative thymocyte-specific enhancer augments Notch1 signaling to direct early T cell progenitor expansion, lineage restriction and β-selection.
Kashiwagi M, Figueroa D, Ay F, Morgan B, Georgopoulos K
Nat Immunol. 2022; 23(11):1628-1643.
PMID: 36316479
PMC: 10187983.
DOI: 10.1038/s41590-022-01322-y.
hiPSC-derived bone marrow milieu identifies a clinically actionable driver of niche-mediated treatment resistance in leukemia.
Pal D, Blair H, Parker J, Hockney S, Beckett M, Singh M
Cell Rep Med. 2022; 3(8):100717.
PMID: 35977468
PMC: 9418860.
DOI: 10.1016/j.xcrm.2022.100717.
AIOLOS Variants Causing Immunodeficiency in Human and Mice.
Yamashita M, Morio T
Front Immunol. 2022; 13:866582.
PMID: 35444653
PMC: 9014263.
DOI: 10.3389/fimmu.2022.866582.